BIOMAT Database Logo BIOMAT Database Logo

Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome). 1995

E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Institut für Humangenetik, Medizinische Universität, Lübeck, Germany.

UI MeSH Term Description Entries
D007066 Iduronate Sulfatase An enzyme that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter's syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. EC 3.1.6.13. Hunter Corrective Factor,Iduronatesulfate Sulfohydrolase,Sulfoiduronate Sulfatase,Iduronate Sulfate Sulfatase,Corrective Factor, Hunter,Factor, Hunter Corrective,Sulfatase, Iduronate,Sulfatase, Iduronate Sulfate,Sulfatase, Sulfoiduronate,Sulfate Sulfatase, Iduronate,Sulfohydrolase, Iduronatesulfate
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome).
November 1993, Human molecular genetics,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).
January 1994, Human mutation,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome).
August 1992, Human molecular genetics,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene.
December 1996, American journal of human genetics,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).
November 1992, Human genetics,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
January 1999, Journal of medical genetics,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Mutations in the iduronate-2-sulfatase gene in 12 Spanish patients with Hunter disease.
January 1998, Human mutation,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients.
January 1995, Human mutation,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
[Detection of two novel mutations of iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II].
January 2007, Yi chuan = Hereditas,
E Popowska, and M Rathmann, and A Tylki-Szymanska, and S Bunge, and C Steglich, and E Schwinger, and A Gal
Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.
February 1996, Human genetics,
Copied contents to your clipboard!